Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) on house dust mite (HDM)-specific CD4+ T cells are specialized protein complexes that recognize allergenic peptides derived from mites such as Dermatophagoides pteronyssinus (Der p) and Dermatophagoides farinae (Der f) (Source: PubMed, PMID: 22326457). These TCRs bind to allergen fragments presented by Major Histocompatibility Complex (MHC) class II molecules on the surface of antigen-presenting cells, initiating the allergic immune cascade (Source: NIH, StatPearls, 'Type I Hypersensitivity'). In sensitized individuals, this interaction predominantly triggers a Th2-polarized response, leading to the production of IgE and the recruitment of eosinophils, which are hallmarks of allergic asthma and rhinitis (Source: J Allergy Clin Immunol, 2012). Therapeutic strategies targeting these TCRs, such as allergen-specific immunotherapy (AIT), aim to reprogram the immune system toward tolerance by inducing regulatory T cells (Tregs) or shifting the response to a Th1 profile (Source: Nature Reviews Immunology, 2018). Understanding the specific TCR repertoire involved in HDM sensitivity is crucial for developing precision medicine approaches, including peptide-based vaccines and TCR-targeted therapies (Source: Science Immunology, 2020).
Induction of immune tolerance through T-cell anergy, clonal deletion, or immune deviation from a pro-inflammatory Th2 response to a regulatory (Treg) or Th1 response upon controlled, repeated exposure to specific allergen peptides (Source: Nature Reviews Immunology, 2018; J Allergy Clin Immunol, 2017).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor on house dust mite-specific CD4+ T cells (HDM-specific TCR) (HDM-specific TCR).